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Abstract Apoptosis can be initiated in immortalized cAMP- 
stimulated rat ovarian granulosa cells by induction of wild-type 
p53 activity, lmmunocytochemical studies using confocal micros- 
copy reveal that in apoptotie, unlike in normal growing cells, the 
proteasomes are removed from the nucleus and accumulate 
within the apoptotic blebs at the periphery of the cell. In parallel, 
a striking reorganization of the actin cytoskeleton is observed 
which forms a spherical network separating the apoptotic blebs 
from the cytoplasmic organelles, such as mitochondria nd lipid 
droplets which remain in the perinuclear region. The reorganiza- 
tion of the actin cytoskeleton as well as disappearance of 
proteasomes from the nucleus suggest possible function of 
proteasomes in apoptotic regulation. 
[16]. In such cells, shifting the temperature of growth from 
37°C to 32°C allows the manifestation of the wild-type p53 
phenotype, as evident by up-regulation of the WAF-1/CIP-1 
gene and arrest of cell growth. 
We found that while most of the proteasomes were accu- 
mulated in the apoptotic blebs during programmed cell death, 
the organelles uch as mitochondria and lipid droplets remain 
intact in the perinucomiclear region during this process. Inter- 
estingly, confocal microscopy shows that concomitant with 
the sequestering of the proteasomes, the cytoskeleton is rear- 
ranged creating a barrier which separates organelles from the 
apoptotic blebs. 
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1. Introduction 
Programmed cell death refers to a process in which a spe- 
cific cell population is eliminated from the living organism in 
response to a variety of extracellular and intracellular stimuli 
[1 5]. Some of the morphological and molecular events lead- 
ing to cell death have been characterized in a variety of cell 
types. It is believed that endonucleases [1-5], DNAase [6] and 
cysteine proteases of the ICE (Interleukin-ll3 converting en- 
zymes) family [7,8] are critically involved in this process. It 
seems that molecular events, such as activation of the genes 
coding for the ICE proteases, have been conserved uring 
evolution [9]. Yet it is not clear which proteins are actually 
degraded during apoptosis and which proteases beside the 
ICE-like proteases are involved in protein degradation during 
this process. 
One of the most abundant intracellular proteases, which is 
not compartmentalized in lysosomes but found both in the 
nucleus and in the cytoplasm of cells, is the proteasome 
[10,11]. In its 26S form it is the central protease of the ubi- 
quitin-dependent pathway of protein degradation and has a 
highly conserved structure from yeast to man [12,13]. The 
proteasome is known to degrade a large number of key reg- 
ulatory proteins [14], but its role in apoptosis is as yet un- 
known. It was recently reported that ubiquitin gene expression 
is up-regulated uring apoptosis [15]. However, there is no 
direct evidence for an involvement of the ubiquitin-protea- 
some-dependent degradation i  apoptosis. 
Apoptosis can be induced by overexpression of a tempera- 
ture-sensitive (ts) mutant of the p53 tumor suppressor in 
cAMP-stimulated, ras-SV40 transformed, granulosa cell lines 
*Corresponding author. Fax: +972 8 9344125. 
2. Materials and methods 
2.1. Cell cultures 
Immortalized granulosa cell line (GTS5), transfected by Simian 
virus (SV40) DNA, plus Ha-RAS oncogene and by the temperature- 
sensitive mutant of p53 (p53 val 135), were used for these studies [16]. 
This mutant was found to be temperature-sensitive: at 37°C it be- 
haves like other p53 oncogenic mutants, while at 32°C it possesses a 
wild-type activity. Cells were maintained on Nunc petri dishes con- 
taining DMEM:F12 medium (1:1) supplemented with penicillin (100 
IU/ml) streptomycin (100 lag/ml) and 5°/,, fetal calf serum (FCS) for 24 
h at 37°C and the medium was replaced by serum-free medium in the 
presence or absence of 50 ~tM of forskolin for another 24 h and 
subsequently cells were cultured at 37°C or at 32°C. 
2.2. Biochemical assays 
Cell protein, progesterone production and chymotrypsin-like pro- 
teolytic activity of proteasomes assayed with succinyl-Ala-Ala-Phe-7- 
aminomethylcoumarin were described by us elsewhere [11,16]. 
2.3. Preparation of polyclonal antibodies to proteasomes; gel 
electrophoresis and Western blots 
Polyclonal antibodies to granulosa cell proteasomes were raised in 
rabbits following immunizing the rabbits with pure fraction of 20S 
proteasomes isolated from POGRS1 rat granulosa cells. For isolation 
and purification of the proteasomes, gel-electrophoresis and Western 
blots, see Ref. [11]. 
2.4. Fixation of cells and staining 
Cells were fixed with 3% paraformaldehyde and permeabilized with 
Triton X-100. The detailed procedure of staining the cells with anti- 
proteasomes and anti-human adrenodoxin antibodies i described by 
us elsewhere [11,17]. Staining the actin cytoskeleton by rhodamine 
phalloidin is described by us elsewhere [18]. Staining of DNA with 
4,6-diamido-2-phenylindol hydrochloride (DAP1) was described else- 
where [16]. 
2.5. Fluorescent microscopy 
Fixed and stained cells were inspected in a Zeiss photolII micro- 
scope in a fluorescent mode. For the visualization of DAPI, BP436 
filter was used. 
2.6. Laser confocal microscopy 
Optical sections of the cells were taken with a LSM 400 Zeiss 
confocal microscope (Zeiss, Oberkochen, Germany). Fields of 
256 x 256 pixels were scanned using the plan neofluor 40 x objective 
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and a pinhole size of 8. Due to the resolution limit, optical serial 
sections of a thickness of 0.4 gm were recorded. FITC and rhodamine 
signals were collected in parallel or subsequently using the appropriate 
lasers and filter sets (FITC: laser 488 rim, filter BP 510-525 beam- 
splitter FT 510; rhodamine: laser 543 nm, filter LP 570, beamsplitter 
FT 560). In parallel, the transmission picture was recorded in pseudo 
Nomarsky interference contrast. All pictures were transferred to an 
Indigo 2 (Silicon Graphics, Mt. View, CA, USA) and galleries of the 
256 grayscale pictures were obtained with the program Advanced 
Visual System (Advanced Visual System Inc., Waltham, MA, USA). 
2. 7. Three-dimensional reconstruction 
Picture stacks of serial optic section, recorded via the rhodamine 
and FITC channels, were retraced and assembled using the AVS pro- 
gram. Stereo-pairs were obtained by tilting each individual reconsti- 
tuted image (of the pair) by 5 ° towards the twin image. 
3. Results and discussion 
GTS5 cells expressing the temperature-sensitive mutant of 
p53 were used in this study to examine the distribution of 
proteasomes and mitochondria s well as the organization 
of the actin cytoskeleton during progression of apoptosis. If 
apoptosis is initiated by shifting the incubation temperature 
from 37°C to 32°C, one can follow the progression of typical 
apoptotic events such as formation of apoptotic blebs and 
fragmentation of chromatin [16]. In order to visualize the 
precise location of proteasomes in relationship to the actin 
cytoskeleton and to the mitochondria, we examined the cells 
by confocal microscopy. In non-apoptotic cells double-stained 
with rhodamine phalloidin and antibodies against either pro- 
teasomes or the mitochondrial steroidogenic enzyme adreno- 
doxin we found, in accordance with previous observations, 
that proteasomes were located both in the nucleus and the 
entire cytoplasm (Fig. 1). In apoptotic cells, proteasomes 
were almost totally confined to the blebs as shown clearly 
by scanning the entire cell volume and 3D reconstruction 
(Fig. 2). The change in the intracellular distribution of the 
proteasomes correlated with rearrangement of the actin cyto- 
skeleton which early in apoptosis formed a spherical network 
surrounding the perinuclear volume (Figs. 1 and 2), rather 
than following cell extensions as observed in non-stimulated 
cells. This organization of the actin network was evident 
through the entire cell depth, suggesting the formation of an 
efficient barrier between the apoptotic blebs loaded with pro- 
teasomes and the residual body of the cell including the nu- 
cleus. Most of the nuclei of apoptotic ells remain essentially 
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intact, in spite of the intensive formation of numerous apop- 
totic blebs at the circumference of the cell. 
In non-apoptotic cells, mitochondria were scattered 
throughout the cytoplasm. The actin filaments were organized 
along the entire length of the cell processes (Fig. 1). In con- 
trast, in cells stimulated to undergo apoptosis, mitochondria 
were confined to the perinuclear region and were essentially 
absent from the apoptotic blebs. Here again, the actin cyto- 
skeleton did not penetrate the apoptotic blebs, but assumed a
spherical organization, sending short extensions towards the 
basis of the apoptotic blebs. In most cells stimulated for apop- 
tosis for 24 h, apoptotic blebs loaded with proteasomes were 
still clearly visible. During further progression of apoptosis, 
the actin cytoskeleton collapses, but most of the mitochondria 
remained in the perinuclear space (not shown). 
The actin cytoskeleton seems to be involved in the compart- 
mentalization of proteasomes, ince it was found to reorganize 
itself in the space bordering the main body of the apoptotic 
cell and the apoptotic blebs. The actin cytoskeleton appears 
not to interact directly with the membrane of the apoptotic 
blebs; it rather seems that the inner face of the plasma mem- 
brane changes physically and biochemically during apoptosis. 
It is not clear what causes the actin cytoskeleton to detach 
from the inner face of the plasma membrane. One hypothesis 
is that the proteasome itself is involved in the degradation of 
the actin binding proteins responsible for the association of 
the actin network with the plasma membrane. Recent obser- 
vations suggest hat fodrin, an analog of spectrin, which is a 
major component of the cortical cytoskeleton of most eukar- 
yotic cells, is degraded uring apoptosis in a variety of cells, 
including T-lymphoma cells [19]. Moreover, it is known that 
c~-spectrin can be ubiquitinated [20], and that cells deficient in 
spectrin tend to show a blebbing reminiscent of the morphol- 
ogy of apoptotic ells [21]. In addition, partial degradation of 
actin during apoptosis was observed recently in human leuke- 
mia U93H cells [22]. Therefore a partial degradation of the 
cortical cytoskeleton may be responsible for the blebbing of 
the plasma membrane in apoptosis. 
Up-regulation of ubiquitin gene expression was recently ob- 
served in normal circulating human lymphocytes during apop- 
tosis [15]. Thus, it is likely that the proteolytic activity of 
proteasomes during apoptosis is regulated by increased for- 
mation and availability of ubiquitinated protein substrates. 
The proteasomes inside the apoptotic blebs may trigger the 
shedding of the apoptotic blebs during programmed cell 
---) 
Fig. 1. Translocation of proteasome, mitochondria and actin cytoskeleton during apoptosis. Non-apoptotic cells stained with rabbit antibodies 
to proteasomes (A) or rabbit antibodies to adrenodoxin (a marker for steroidogenic mitochondria) (B) and with rhodamine phalloidin (B'). 
Proteasomes are distributed both in the nucleus and the cytoplasm while mitochondria are distributed in the cytoplasm and cell processes delin- 
eated by actin cables. Apoptotic cell (C) stained with antiproteasome antibodies (C') show a high concentration f proteasomes in apoptotic 
blebs leaving the nucleus free of proteasomes. Reorganization f actin cytoskeleton to a condensed ring is evident (C"). Redistribution of mito- 
chondria in the center of an apoptotic ell (D, D') is characterized by reorganization f the actin cytoskeleton i a ring shape (D"). Apoptotic 
cells (C,D) were pretreated with 50 ~tM forskolin for 20 h at 37°C and stimulated for 5 h at 32°C in serum-free medium in the presence of for- 
skolin. Control and apoptotic ells were fixed with 3% formaldehyde and permeabilized with Triton X-100. A,B,B',C',C",D',D" fluorescent 
images in a laser confocal microscope (Ziess, 410; optical sections of 0.4 gm. L---, ~ H, false colour intensity gradient; blue, lowest level; red, 
highest level). C,D, interference optic. Bar, 10 gm. 
Fig. 2. Stereo-pair of three-dimensional reconstitution of optical sections of a cell stained with rhodamine phalloidine for actin filaments and 
rabbit antibodies to proteasomes followed by FITC goat anti-rabbit IgG. Apoptotic ell preteated with forskolin at 37°C and stimulated for 5 h 
at 32°C in serum-free medium in the presence of 50 gM forskolin. Proteasomes are almost exclusively located in apoptotic blebs and actin 
cytoskeleton reorganized in a spherical basket which seems to separate the apoptotic blebs from the main cell body. Picture size 25 ~tm. 
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death. On the other hand, preservation of the integrity of the 
steroidogenic mitochondria nd lipid droplets and their clus- 
tering in the perinuclear region may explain the preservation 
and even enhancement of steroidogenesis during early stages 
of apoptosis [16]. 
It is also worth considering that p53 plays an important 
role in the induction and probably in the maintenance of 
apoptosis in GTS cells as in other cell types, p53 has been 
shown to be degraded via ubiquitination [23]. It was recently 
demonstrated that shifting the growth temperature from 37°C 
to 32°C in cells expressing the p53Val135 leads to its translo- 
cation to the nucleus and enhancement of its degradation, 
probably via ubiquitin-p53 and 26S proteasome interaction 
[24~26]. Translocation of proteasomes from the nucleus to 
the apoptotic blebs, as evident from our studies, may rescue 
the nuclear p53 from further degradation and thus play a role 
in the triggering of apoptosis. It remains to be seen whether 
turnover of nuclear p53 is indeed significantly reduced uring 
initial steps of apoptosis. 
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